Low-intensity indocyanine-green laser phototherapy of acne vulgaris: Pilot study

Journal of Biomedical Optics

Volumn 9, Issue 4, 2004, Pages 828-834

  Genina, Elina A ^a   Bashkatov, Alexey N ^a   Simonenko, Georgy V ^a   Odoevskaya, Olga D ^b   Tuchin, Valery V ^c   Altshuler, Gregory B ^d  

^a SARATOV STATE UNIVERSITY   (Russian Federation)

^b SARATOV STATE MEDICAL UNIVERSITY   (Russian Federation)

^c Optics Department   (Russian Federation)

^d Palomar Medical Technologies Inc   (United States)

Author keywords

Acne vulgaris; Indocyanine green; NIR laser irradiation; Photodynamic therapy

Indexed keywords

ACNE VULGARIS; INDOCYANINE GREEN; LASER PHOTOTHERAPY; NEAR INFRARED DIODE LASER;

BACTERIA; DISEASES; INFRARED RADIATION; LASER BEAM EFFECTS; MEDICAL IMAGING; RADIOTHERAPY; SEMICONDUCTOR LASERS; SKIN;

PHOTODYNAMIC THERAPY;

INDOCYANINE GREEN; PHOTOSENSITIZING AGENT;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; INFRARED RADIATION; MALE; METHODOLOGY; PATHOLOGY; PHOTOCHEMOTHERAPY; PILOT STUDY; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INDOCYANINE GREEN; INFRARED RAYS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 4444344676     PISSN: 10833668     EISSN: None     Source Type: Journal    
DOI: 10.1117/1.1756596     Document Type: Article

References (57)

1. W. J. Cunliffe and N. B. Simpson, "Disorders of the sebaceous glands," in Textbook of Dermatology, R. H. Champion, J. L. Burton, D. A. Burns, and S. M. Breathnach, Eds., Blackwell Science, Oxford (1998).
2. W. J. Cunliffe, Acne, Martin Dunitz, Year Book Medical Publishers, Chicago (1989).
3. V. P. Adaskevich, Acne and Rosazea, Olga, St. Petersburg (2000).
4. W. J. Cunliffe and V. Goulden, "Phototherapy and acne vulgaris," Br. J. Dermatol. 142, 853-856 (2000).
5. A. L. Wright and G. B. Colver, "Tetracyclines - how safe are they?" Clin. Exp. Dermatol. 13, 57-61 (1988).
6. M. Pepine, F. P. Flowers, and F. A. Ramos-Caro, "Extensive cutaneous hyperpigmentation caused by minocycline," J. Am. Acad. Dermatol. 28, 292-295 (1993).
7. A. Gough, S. Chapman, K. Wagstaff et al., "Minocycline-induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome," Br. Med. J. 320, 169-172 (1996).
8. R. S. Stern, "When a uniquely effective drug is teratogenic: the case of isotretinoin," New Engl. J. Med. 320, 1007-1009 (1989).
9. J. P. Grifiin, "A review of the literature on benign intracranial hypertension associated with medication," Adverse Drug Reactions Toxicol. Rev. 11, 41-58 (1992).
10. C. Hong Ng and I. Schweitzer, "The association between depression and isotretinoin use in acne," Austral. N. Zeal. J. Psychiat. 37, 78-84 (2003).
11. K. Charalabopoulos, V. Papalimneous, A. Charalabopoulos, and J. Hatzis, "Two new adverse effects of isotretinoin," Br. J. Dermatol. 148, 593 (2003).
12. A. H. Lewin, M. E. Bos, F. C. Zusi, X. Nair, G. Whiting, P. Bouquin, G. Tetrault, and F. I. Carroll, "Evaluation of retinoids as therapeutic agents in dermatology," Pharmaceut. Res. 11(2), 192-200 (1994).
13. J. Czernielewski, S. Michel, M. Bouclier et al., "Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne," JEADV 15, 5-12 (2001).
14. J. E. Wolf, "An update of recent clinical trials examining adapalene and acne," JEADV 15, 23-29 (2001).
15. S. Bershad, G. K. Singer, J. E. Parente et al., "Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel," Arch. Dermatol. 138, 481-489 (2002).
16. L. A. Drake, "Guidelines of care for acne vulgaris," J. Am. Acad. Dermatol. 22, 676-680 (1990).
17. E. A. Eady, M. R. Farmery, J. I. Ross et al., "Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients," Br. J. Dermatol. 131, 331-336 (1994).
18. J. J. Leyden, K. J. McGinley, S. Cavalieri, G. F. Webster, O. H. Mills, and A. M. Kligman, "Propionibacterium acnes resistance to antibiotics in acne patients," J. Am. Acad. Dermatol. 8, 41-45 (1983).
19. E. A. Eady, C. E. Jones, J. L. Tipper, J. H. Cove, W. J. Cunliffe, and A. M. Layton, "Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage," Br. Med. J. 306, 555-556 (1993).
20. J. T. Magee and E. L. Pitchard, "Antibiotic prescribing and antibiotic resistance in community practice: Retrospective," Br. Med. J. 319, 1239-1240 (1999).
21. J. J. Leyden, "Current issues in antimicrobial therapy for the treatment of acne," JEADV 15, 51-55 (2001).
22. A. J. Cooper, "Treatment of acne with isotretinoin: recommendations based on Australian experience," Australasian J. Dermatol. 44, 97-105 (2003).
23. B. Kjeldstad and A. Johnsson, "An action spectrum for blue and near ultraviolet inactivation of Propionibacterium acnes; with emphasis on a possible porphyrin photosensitization," Photochem. Photobiol. 43, 67-70 (1986).
24. O. H. Mills, M. Porte, and A. M. Kligman, "Enhancement of comedogenic substances by ultraviolet radiation," Br. J. Dermatol. 98, 145-148 (1978).
25. H. Meffert, K. Gaunitz, T. Gutewort, and U. J. Amlong, "Therapy of acne with visible light. Decreased irradiation time by using a blue-light high-energy lamp," Dermatol. Monatsschr. 176(10), 597-603 (1990).
26. Z. Malik, H. Ladan, B. Ehrenberg, and Y. Nitzan, "Bacterial and vital photodynamic inactivation," in Photodynamic Therapy: Basic Principles and Clinical Applications, B. Henderson and T. Dougherty, Eds., pp. 97-113, Marcel Dekker, New York (1992).
27. G. Jori and D. Tonlorency, "Photodynamic treatment of microbial infections," Photodynamic News 2(1), 2-3 (1999).
28. A. R. Shalita, Y. Harth, M. Elman, M. Slatkine, G. Talpalariu, Y. Rosenberg, A. Korman, and A. Klein, "Acne phototherapy using UV-free high-intensity narrow-band blue light: 3 center clinical study," Proc. SPIE 4244, 61-73 (2001).
29. V. Sigurdsson, A. C. Knulst, and van H. Weelden, "Phototherapy of acne vulgaris with visible light," Dermatology 194, 256-260 (1997).
30. P. Papageorgiou, A. Katsambas, and A. Chu, "Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris," Br. J. Dermatol. 142, 973-978 (2000).
31. g) generation from coproporphyrin in Propionibacterium aches on irradiation," Biochem. Biophys. Res. Commun. 223, 578-582 (1996).
32. S. Yong, P. Bolton, M. Dyson et al., "Macrophage responsiveness to light therapy," Lasers Surg. Med. 9, 497-505 (1989).
33. W. Yu, J. O. Naim, and K. J. Lonzafame, "Effects of photostimulation on wound healing in diabetic mice," Lasers Surg. Med. 20, 56-63 (1997).
34. W. Hongcharu, C. R. Taylor, Y. Chang, D. Aghassi, K. Suthamjariya, and R. R. Anderson, "Topical ALA-photodynamic therapy for the treatment of acne vulgaris," J. Invest. Dermatol. 115, 183-192 (2000).
35. K. Koenig and H. Meyer, "Photodynamic activity of methylene blue," Akt. Dermatol. 19, 195-198 (1993).
36. K. Koenig, M. Teschke, S. Eick, W. Pfister, H. Meyer, and K.-J. Halbhuber, "Photodynamical inactivation of Propionibacterium acnes," Proc. SPIE 3247, 106-110 (1998).
37. I. J. Fox and E. H. Wood, "Indocyanine green: physical and physiologic properties," Staff Meetings of the Mayo Clinic 35(25), 732-744 (1960).
38. F. J. Green, The Sigma-Aldrich Handbook of Stains, Dyes and Indicators, Aldrich Chemical Co., Milwaukee, WI (1990).
39. S. L. Jacques's website: www.omlc.ogi.edu.
40. H. I. Pass, "Photodynamic therapy in oncology: mechanisms and clinical use," J. Natl. Cancer Inst. 85, 443-456 (1993).
41. W. R. Chen, R. L. Adams, S. Heaton, D. T. Dickey, K. E. Bartels, and R. E. Nordquist, "Chromophore-enhanced laser-tumor tissue photothermal interaction using an 808-nm diode laser," Cancer Lett. 88, 15-19 (1995).
42. W. R. Chen, R. L. Adams, K. E. Bartels, and R. E. Nordquist, "Chromophore-enhanced in vivo tumor cell destruction using an 808-nm diode laser," Cancer Lett. 94, 125-131 (1995).
43. W. R. Chen, R. L. Adams, A. K. Higgins, K. E. Bartels, and R. E. Nordquist, "Photothermal effects on mammary tumor using indocyanine green and an 808-nm diode laser: in vivo efficacy study," Cancer Lett. 98, 169-173 (1996).
44. S. Fickweiler, R. M. Szeimies, W. Baumler, P. Steinbach, S. Karrer, A. E. Goetz, C. Abels, F. Hofstadter, and M. Landthaler, "Indocyanine green: intracellular uptake and phototherapeutic effects in vitro," J. Photochem. Photobiol. B Biol. 38, 178-183 (1997).
45. W. Baumler, C. Abels, S. Karrer, T. Weis, H. Messmann, M. Landthaler, and R.-M. Szeimies, "Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light," Br. J. Cancer 80(3/4), 360-363 (1999).
46. C. Abels, S. Fickweiler, P. Weiderer, W. Baumler, F. Hofstadter, M. Landthaler, and R.-M. Szeimies, "Indocyanine green (ICG) and laser irradiation induce photooxidation," Arch. Dermatol. Res. 292, 404-411 (2000).
47. J. R. Lloyd and M. Mirkov, "Selective photothermolysis of the sebaceous glands for acne treatment," Lasers Surg. Med. 31, 115-120 (2002).
48. V. V. Tuchin, E. A. Genina, A. N. Bashkatov, G. V. Simonenko, O. D. Odoevskaya, and G. B. Altshuler, "A pilot study of ICG laser therapy of acne vulgaris: photodynamic and photothermolysis treatment," Lasers Surg. Med. 33, 296-310 (2003).
49. J. Pearce and S. Thomsen, "Rate process analysis of thermal damage," in Optical-Thermal Response of Laser-Irradiated Tissue, A. J. Welch and M. J. C. Van Gemert, Eds., Plenum, New York (1995).
50. E. A. Genina, A. N. Bashkatov, Yu. P. Sinichkin, V. I. Kochubey, N. A. Lakodina, O. A. Perepelitzina, G. B. Altshuler, and V. V. Tuchin, "In vitro and in vivo study of dye diffusion into the human skin and hair follicles," Proc. SPIE 4162, 63-70 (2000).
51. I. V. Fedosov, D. A. Zimnyakov, V. V. Tuchin, E. A. Genina, and G. B. Altshuler, "Double-wavelength laser scanning microphotometer (DWLSM) for in vitro hair shaft and surrounding tissue imaging," Proc. SPIE 4244, 152-155 (2001).
52. E. A. Genina, A. N. Bashkatov, Yu. P. Sinichkin, V. I. Kochubey, N. A. Lakodina, G. B. Altshuler, and V. V. Tuchin, "In vitro and in vivo study of dye diffusion into the human skin and hair follicles," J. Biomed. Opt. 7(3), 471-477 (2002).
53. V. V. Tuchin, I. S. Ovchinnikov, D. E. Popov, and G. B. Altshuler, "ICG-LED (810 nm) photodynamic inactivation of bacterial microorganisms," J. Technical Phys. Lett. (in press).
54. K. Jimbow, W. C. Quevedo, T. B. Fitzpatrick Jr., and G. Szabo, "Biology of melanocytes. Dermatology," in General Medicine, T. B. Fitzpatrick Jr., A. Z. Eisen, K. Wolff, I. M. Freedberg, and K. F. Austen, Eds., McGraw-Hill, New York (1993).
55. C. C. Zouboulis, "Exploration of retinoid activity and the role of inflammation in acne: issues affecting future directions for acne therapy," JEADV 15, 63-67 (2001).
56. C. A. Nanni and T. S. Alster, "Laser-assisted hair removal: side effects of Q-switched Nd:YAG, long-pulsed ruby and alexandrite lasers," J. Am. Acad. Dermatol. 41(2), 165-171 (1999).
57. W. Manuskiatti, C. C. Dierickx, S. Gonzalez, T.-Y. D. Lin, V. B. Campos, E. Gonzalez, and R. R. Anderson, "Laser hair removal affects sebaceous glands and sebum excretion: a pilot study," J. Am. Acad. Dermatol. 41(2), 176-180 (1999).